Brief: India's Dr. Lal Pathlabs Sept-Quarter Consol Net Profit 950 Mln Rupees
26/10/2021 12:19
Oct 26 (Reuters) - Dr. Lal PathLabs Ltd DLPA.NS :
* INDIA'S DR. LAL PATHLABS SEPT-QUARTER CONSOL NET PROFIT
950
MILLION RUPEES VERSUS 853 MILLION RUPEES YEAR AGO
* DR. LAL PATHLABS SEPT-QUARTER CONSOL REVENUE FROM
OPERATIONS
4.98 BILLION RUPEES VERSUS 4.32 BILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSE6P5Rzk
Further company coverage: DLPA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise